The Ensign Group Company Profile (NASDAQ:ENSG)

The Ensign Group trades on the NASDAQ under the ticker symbol "ENSG."

The Ensign Group announced a quarterly dividend on Tuesday, September 12th. Investors of record on Saturday, September 30th will be given a dividend of $0.043 per share on Tuesday, October 31st. This represents a $0.17 annualized dividend and a dividend yield of 0.83%. The ex-dividend date of this dividend is Thursday, September 28th. View The Ensign Group's Dividend History.

The Ensign Group shares split before market open on Thursday, December 24th 2015. The 2-1 split was announced on Wednesday, December 9th 2015. The newly minted shares were payable to shareholders after the market closes on Wednesday, December 23rd 2015. An investor that had 100 shares of The Ensign Group stock prior to the split would have 200 shares after the split.

The Ensign Group declared that its Board of Directors has authorized a stock buyback program on Wednesday, April 12th 2017, which permits the company to repurchase $30,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board believes its shares are undervalued.

The Ensign Group, Inc. (NASDAQ:ENSG) issued its earnings results on Monday, May, 1st. The company reported $0.34 EPS for the quarter, topping the Zacks' consensus estimate of $0.33 by $0.01. The company had revenue of $441.74 million for the quarter, compared to analysts' expectations of $435.72 million. The Ensign Group had a net margin of 2.54% and a return on equity of 13.01%. View The Ensign Group's Earnings History.

The Ensign Group is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for The Ensign Group.

The Ensign Group issued an update on its FY17 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $1.46-1.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.49. The company issued revenue guidance of $1.76-1.80 billion, compared to the consensus revenue estimate of $1.78 billion.

5 brokerages have issued 1-year target prices for The Ensign Group's stock. Their predictions range from $18.00 to $26.00. On average, they expect The Ensign Group's share price to reach $22.00 in the next twelve months. View Analyst Ratings for The Ensign Group.

Here are some recent quotes from research analysts about The Ensign Group stock:

• 1. According to Zacks Investment Research, "The Ensign Group’s operation suffers severely from rising expenses that keeps draining the bottom line. Moreover, the company’s extensive use of debt keeps raising the cost of borrowing, i.e. the interest expense which in turn hurts its profitability. The company also faces difficulties in the stringent regulatory environment of the U.S medical sector. Also, regulations faced by the non-U.S. operations of the company keep raising concerns. Year to date, its shares have underperformed the industry as well. However, it operates in the booming post-acute care industry that holds untapped opportunities. Its inorganic strategies consistently boost the revenue base. Its solid financial health enables it in enhancing shareholders’ value. Its second-quarter 2017 earnings missed the Zacks Consensus Estimate but increased year over year driven by higher revenues. Management reaffirmed 2017 EPS and revenue guidance which indicate optimism." (8/8/2017)
• 2. Cantor Fitzgerald analysts commented, "Updated Outlook. Our full year 2016 adjusted EPS estimate moves to $1.35 (from $1.40) roughly in line with Bloomberg consensus and management guidance of $1.35-1.42. Our quarterly 2017 estimates move slightly but we are maintaining our full year adjusted EPS estimate of $1.65, two cents above Bloomberg consensus of $1.63. We are introducing a 2018 estimate of $1.80, which compares to current Bloomberg consensus of $1.75. Future operational upside. While 3Q16 saw 196 bp decline in same- store occupancy, it was mostly contained to a few particular geographies, predominantly Texas with select locations in Washington and Utah. This softness was partially offset by 126 bp increase in managed care days. Additionally, skilled days increased 750 bps and assisted living patient days increased 67 bps." (12/15/2016)

Some companies that are related to The Ensign Group include AMN Healthcare Services (AMN), Healthways (TVTY), Spire Healthcare Group PLC (SPI), U.S. Physical Therapy (USPH), Surgery Partners (SGRY), BioScrip (BIOS), AAC Holdings (AAC), Quorum Health Corporation (QHC), Envision Healthcare Corp (AMSG) and Mediclinic International PLC (ANH).

The Ensign Group's management team includes the folowing people:

• Roy E. Christensen, Chairman of the Board, Co-Founder
• Christopher R. Christensen, President, Chief Executive Officer, Co-Founder, Director
• Suzanne D. Snapper, Chief Financial Officer
• Chad A. Keetch, Executive Vice President, Secretary
• Beverly B. Wittekind, Vice President, General Counsel
• Barry R. Port, Chief Operating Officer - Ensign Services, Inc
• Lee A. Daniels, Independent Director
• Antoinette T. Hubenette M.D., Independent Director
• John G. Nackel Ph.D., Independent Director
• Daren J. Shaw, Independent Director

The Ensign Group's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Wasatch Advisors Inc. (12.95%), BlackRock Inc. (11.74%), Vanguard Group Inc. (8.83%), Dimensional Fund Advisors LP (4.31%), State Street Corp (2.54%) and Denver Investment Advisors LLC (2.18%). Company insiders that own The Ensign Group stock include Antoinette T Hubenette, Barry Port, Beverly B Wittekind, Chad Keetch, Christopher R Christensen, John G Nackel, Lee A Daniels, Roy E Christensen and Suzanne D Snapper. View Institutional Ownership Trends for The Ensign Group.

The Ensign Group's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, BTIM Corp., Thrivent Financial For Lutherans, Heartland Advisors Inc., Parametric Portfolio Associates LLC, JPMorgan Chase & Co., Royce & Associates LP and Public Employees Retirement System of Ohio. Company insiders that have sold The Ensign Group stock in the last year include Antoinette T Hubenette, Barry Port, Beverly B Wittekind, Chad Keetch and Suzanne D Snapper. View Insider Buying and Selling for The Ensign Group.

The Ensign Group's stock was purchased by a variety of institutional investors in the last quarter, including Denver Investment Advisors LLC, Ameriprise Financial Inc., Copeland Capital Management LLC, Wasatch Advisors Inc., Kestrel Investment Management Corp, Bridge City Capital LLC, Northern Trust Corp and Vanguard Group Inc.. View Insider Buying and Selling for The Ensign Group.

Shares of The Ensign Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of The Ensign Group stock can currently be purchased for approximately $20.77.